Sunho Biologics, Inc. (HKG:2898)
Hong Kong · Delayed Price · Currency is HKD 6.40
0.00 (0.00%)
Mar 6, 2026, 1:25 PM HKT
Sunho Biologics Market Cap
Sunho Biologics has a market cap or net worth of 970.43 million as of July 31, 2026. Its market cap has increased by 51.19% in one year.
Market Cap
970.43M
Enterprise Value
596.44M
Revenue
18.63K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.40
ChartMarket Cap Chart
Since May 24, 2024, Sunho Biologics's market cap has decreased from 2.19B to 970.43M, a decrease of -55.64%. That is a compound annual growth rate of -35.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 970.43M | -3.77% |
| Dec 31, 2025 | 1.01B | 78.00% |
| Dec 31, 2024 | 566.51M | -74.10% |
| May 24, 2024 | 2.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.43B |
| Zhaoke Ophthalmology | 1.40B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.32B |
| Beijing Biostar Pharmaceuticals | 1.29B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.26B |
| CANbridge Pharmaceuticals | 1.18B |
| Cloudbreak Pharma | 1.01B |
| Cutia Therapeutics | 875.72M |